Key facts
- Embr Labs’s last known valuation is $8.0M (Oct 2024).
- It has raised $57.0M across 3 recorded rounds; the latest was Seed Round ($3.0M) in Oct 2024.
- Notable investors include US National Science Foundation, MassChallenge, United States Department of War, Intel Capital, Joyance Partners — 23 tracked in total.
- Embr Labs has filed 4 Form Ds with the SEC since 2015, most recently Oct 2024 ($3.0M sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Embr Labs
Funding rounds
3 roundsAbout Embr Labs
Developer of a wearable thermal device designed to help individuals regulate personal comfort through targeted temperature control. The company offers a wrist-worn, app-connected device that delivers precise warming and cooling sensations, enabling people experiencing hot flashes, sleep disturbances, stress, or discomfort to achieve natural and on-demand relief.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2013
- Employees
- 20
- Website
- embrlabs.com/
- Ownership
- Privately Held (backing)
Embr Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Embr Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Embr Labs in its N-PORT filings yet. We sweep new filings monthly.